TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Substance use at 1-month follow-up
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Smoking cessation rates at 26 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental Component Score improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: LLI block achievement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VOM length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early recurrences within 3 months
Endpoint domain: Adverse events/effects
Primary endpoint: short-term benefits of acupuncture for knee osteoarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean daily number of hot flushes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean daily number of nocturnal sweats
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GHT score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: WPPSI score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: WPPSI attention‐concentration subscale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: WPPSI pure attention subscale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Five-year disease free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: 360-day mortality
Endpoint domain: Mortality/survival
Primary endpoint: Unmasking of children
Endpoint domain: Physiological/clinical
Primary endpoint: number of social supports
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: No hospital mortality
Endpoint domain: Mortality/survival
Primary endpoint: No reoperation
Endpoint domain: Adverse events/effects
Primary endpoint: Maintenance of Physical Activity (PA)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ICU Length of Stay (LOS)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Manual muscle test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of bone defect depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Defect angle measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight loss improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monthly binge eating episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: obvious growth and physical changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: teasing because of short stature
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: improvement of well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Average score in MCQs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported understanding of message contents
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rating of messages as helpful
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: time to state the date of birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Four-fold or greater increases in serum HAI titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Post-vaccination titers of > 1:40
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence of breakthrough bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in platelet aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Decrease in pulmonary artery pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Flow rate of the Baxter LV10 InfusorTM device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung function (FEV1 and FEF50)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Injection site soreness
Endpoint domain: Adverse events/effects
Primary endpoint: Injection site bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Measles titers above baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mumps titers above baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rubella titers above baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Completion of health care proxy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical results (excellent or good)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower esophageal sphincter length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Lower esophageal sphincter pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: rehospitalisation with acute myocardial infarction or death
Endpoint domain: Mortality/survival
Primary endpoint: Areas under inhibitory curve (AUICs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain relief for PICC insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severity of pain in the legs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month symptoms in the feet and legs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of tier 1 safety events
Endpoint domain: Adverse events/effects
Primary endpoint: Peak Cough Flow (PCF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of aggressive behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of the connubial or cohabitation relationship
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total costs at 12 months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quality of Life functioning scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Visualization ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time for 4QB sampling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of saline flushes needed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concern about weight
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Uncorrected near visual acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality ratings of unaided near vision
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complaints from cataract symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Change in absolute astigmatism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sweat accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blister incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hot spot incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blister severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: irritant dermatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Total dose of propofol required
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of CD4 cell count less than 350 cells/μl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: dental plaque levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: denture plaque levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of hepatitis due to HBV reactivation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Severity of hepatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality related to hepatitis
Endpoint domain: Mortality/survival
Primary endpoint: Median time to last diarrheal stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Median time to resolution of associated symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of nausea after dosing
Endpoint domain: Adverse events/effects
Primary endpoint: mean cumulative nitrogen balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ecological validity of decision-making processes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Being free from PD ≥5 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate for panic disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical improvement in panic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate for depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spine BMD response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip BMD response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thyroid-stimulating hormone (TSH) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Calcium (CA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Haemoglobin (HB) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cobalamin (COBA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Creatinine (CREA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of subjects remaining dippers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of filtering surgery
Endpoint domain: Mortality/survival
Primary endpoint: Median filter survival time
Endpoint domain: Mortality/survival
Primary endpoint: Protective effect against CKD G3-G5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Higher eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Complex S. aureus SSIs rate
Endpoint domain: Adverse events/effects
Primary endpoint: KCCQ overall summary scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cystatin-C concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete eyelid akinesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CHF and atrial fibrillation incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical and radiographic bone gains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Day-to-day airway obstruction control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: prevalence of hyperpolypharmacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PET negativity rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapeutic recommendation change
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Postoperative pain scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nausea reduction
Endpoint domain: Adverse events/effects
Primary endpoint: visceral/sc fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: androstenedione
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Rate of improvement in borderline psychopathology symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported cumulative toxicity scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: frequency of self‐reported brushing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: periodontal health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral health‐related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CWPCS improvement at 6 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistent renal impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Death or readmission for cardiovascular or renal causes
Endpoint domain: Mortality/survival
Primary endpoint: Time to neutrophil engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean serum VEGF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum IgG subclass concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: maximal ATP synthetic capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No bothersome incontinence symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in IGF‐1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: falls occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vocal functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nystagmus acuity function across gaze
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ETDRS binocular letter visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Knowledge of TB
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum levels of TGF‐beta1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lp(a) lipoprotein serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: No evidence of corneal or conjunctival abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evidence of papillary hypertrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive conjunctival cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: healthcare use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total PGC‐1α mRNA abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Vascular endothelial growth factor mRNA abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Hif‐1α mRNA abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak oxygen uptake (VO2peak)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neck mobility scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of late hemispheric transient ischemic attacks
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of late retinal transient ischemic attacks
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of late strokes
Endpoint domain: Mortality/survival
Primary endpoint: Total incidence of nausea and vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of vomiting episodes >4 times
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of patients requiring rescue antiemetics
Endpoint domain: Adverse events/effects
Primary endpoint: mean number of weaknesses commented on
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Re-excision or mastectomy rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pain freedom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from the MBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematoma occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Scar retraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: mean maximal urinary flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent in A&E
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of varicella lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of fever and constitutional symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Congenital anomalies in live-born infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Early pregnancy loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Rates of treatment success (no need for transfusion and hemoglobin never below 8 g/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean effective dose of low-dose CT scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: National Institutes of Health Stroke Scale improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: tibial rotational excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: side effects attributable to the stent
Endpoint domain: Adverse events/effects
Primary endpoint: Removal of guns from the home
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Acquisition of guns over 2-year follow-up
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Segmental LS values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in reading continuous print
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to spot read
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: asymptomatic days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: days with severe symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daytime somnolence
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: daytime activity levels
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: rest-activity rhythm amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CFQ‐R‐Respiratory Symptoms Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: log(10) sputum PA colony‐forming units
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: relative FEV(1)% predicted
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Lipid profile (triglycerides)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement of coordination problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease of balance problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: throat pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suicidal thoughts
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Average time to initial analgesic requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in spasticity (Ashworth Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthma management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety scores (STAI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HbA1c changes from baseline at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma lidocaine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean seated cuff trough SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hypertension goal attainment rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean scores on ease of use, product knowledge, and purchase intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cumulative incidence of atopic disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: involvement score of the oral mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimally acceptable initial care offered
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention